Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where J.A. Villar is active.

Publication


Featured researches published by J.A. Villar.


The Lancet | 2014

International standards for newborn weight, length, and head circumference by gestational age and sex: the Newborn Cross-Sectional Study of the INTERGROWTH-21st Project

J.A. Villar; Leila Cheikh Ismail; Cesar G. Victora; E O Ohuma; Enrico Bertino; Doug Altman; Ann Lambert; A T Papageorghiou; M. Carvalho; Y A Jaffer; Michael G. Gravett; Manorama Purwar; Io Frederick; Alison Noble; R Pang; Fernando C. Barros; Cameron Chumlea; Zulfiqar A. Bhutta; S Kennedy

BACKGROUND In 2006, WHO published international growth standards for children younger than 5 years, which are now accepted worldwide. In the INTERGROWTH-21(st) Project, our aim was to complement them by developing international standards for fetuses, newborn infants, and the postnatal growth period of preterm infants. METHODS INTERGROWTH-21(st) is a population-based project that assessed fetal growth and newborn size in eight geographically defined urban populations. These groups were selected because most of the health and nutrition needs of mothers were met, adequate antenatal care was provided, and there were no major environmental constraints on growth. As part of the Newborn Cross-Sectional Study (NCSS), a component of INTERGROWTH-21(st) Project, we measured weight, length, and head circumference in all newborn infants, in addition to collecting data prospectively for pregnancy and the perinatal period. To construct the newborn standards, we selected all pregnancies in women meeting (in addition to the underlying population characteristics) strict individual eligibility criteria for a population at low risk of impaired fetal growth (labelled the NCSS prescriptive subpopulation). Women had a reliable ultrasound estimate of gestational age using crown-rump length before 14 weeks of gestation or biparietal diameter if antenatal care started between 14 weeks and 24 weeks or less of gestation. Newborn anthropometric measures were obtained within 12 h of birth by identically trained anthropometric teams using the same equipment at all sites. Fractional polynomials assuming a skewed t distribution were used to estimate the fitted centiles. FINDINGS We identified 20,486 (35%) eligible women from the 59,137 pregnant women enrolled in NCSS between May 14, 2009, and Aug 2, 2013. We calculated sex-specific observed and smoothed centiles for weight, length, and head circumference for gestational age at birth. The observed and smoothed centiles were almost identical. We present the 3rd, 10th, 50th, 90th, and 97th centile curves according to gestational age and sex. INTERPRETATION We have developed, for routine clinical practice, international anthropometric standards to assess newborn size that are intended to complement the WHO Child Growth Standards and allow comparisons across multiethnic populations. FUNDING Bill & Melinda Gates Foundation.


The New England Journal of Medicine | 1991

Calcium supplementation to prevent hypertensive disorders of pregnancy.

José M. Belizán; J.A. Villar; Laura Gonzalez; Liana Campodonico; Eduardo Bergel

Abstract Background. Calcium supplementation has been reported to reduce blood pressure in pregnant and nonpregnant women. We undertook this prospective study to determine the effect of calcium supplementation on the incidence of hypertensive disorders of pregnancy (gestational hypertension and preeclampsia) and to determine the value of urinary calcium levels as a predictor of the response. Methods. We studied 1194 nulliparous women who were in the 20th week of gestation at the beginning of the study. The women were randomly assigned to receive 2 g per day of elemental calcium in the form of calcium carbonate (593 women) or placebo (601 women). Urinary excretion of calcium and creatinine was measured before calcium supplementation was begun. The women were followed to the end of their pregnancies, and the incidence of hypertensive disorders of pregnancy was determined. Results. The rates of hypertensive disorders of pregnancy were lower in the calcium group than in the placebo group (9.8 percent vs. 14.8...


American Journal of Obstetrics and Gynecology | 2008

Maternal infection and risk of preeclampsia: Systematic review and metaanalysis

Agustin Conde-Agudelo; J.A. Villar; Marshall D. Lindheimer

There are lingering questions regarding the association between maternal infection and preeclampsia. Systematic review and metaanalysis was conducted of observational studies that examined the relationship between maternal infection and preeclampsia. Forty-nine studies met the inclusion criteria. The risk of preeclampsia was increased in pregnant women with urinary tract infection (pooled odds ratio, 1.57; 95% CI, 1.45-1.70) and periodontal disease (pooled odds ratio, 1.76; 95% CI, 1.43-2.18). There were no associations between preeclampsia and presence of antibodies to Chlamydia pneumoniae, Helicobacter pylori, and cytomegalovirus, treated and nontreated HIV infection, and malaria. Individual studies did not find a relationship between herpes simplex virus type 2, bacterial vaginosis, and Mycoplasma hominis and preeclampsia. Urinary tract infection and periodontal disease during pregnancy are associated with an increased risk of preeclampsia. More studies are required to verify this as well as to explore whether or not such relationships are causal and, if so, the mechanisms involved.


The Lancet | 2014

International standards for fetal growth based on serial ultrasound measurements: the Fetal Growth Longitudinal Study of the INTERGROWTH-21st Project

A T Papageorghiou; E O Ohuma; Douglas G. Altman; Tullia Todros; Leila Cheikh Ismail; Ann Lambert; Y A Jaffer; Enrico Bertino; Michael G. Gravett; Manorama Purwar; J. Alison Noble; R Pang; Cesar G. Victora; Fernando C. Barros; M. Carvalho; L. J. Salomon; Zulfiqar A. Bhutta; S Kennedy; J.A. Villar

BACKGROUND In 2006, WHO produced international growth standards for infants and children up to age 5 years on the basis of recommendations from a WHO expert committee. Using the same methods and conceptual approach, the Fetal Growth Longitudinal Study (FGLS), part of the INTERGROWTH-21(st) Project, aimed to develop international growth and size standards for fetuses. METHODS The multicentre, population-based FGLS assessed fetal growth in geographically defined urban populations in eight countries, in which most of the health and nutritional needs of mothers were met and adequate antenatal care was provided. We used ultrasound to take fetal anthropometric measurements prospectively from 14 weeks and 0 days of gestation until birth in a cohort of women with adequate health and nutritional status who were at low risk of intrauterine growth restriction. All women had a reliable estimate of gestational age confirmed by ultrasound measurement of fetal crown-rump length in the first trimester. The five primary ultrasound measures of fetal growth--head circumference, biparietal diameter, occipitofrontal diameter, abdominal circumference, and femur length--were obtained every 5 weeks (within 1 week either side) from 14 weeks to 42 weeks of gestation. The best fitting curves for the five measures were selected using second-degree fractional polynomials and further modelled in a multilevel framework to account for the longitudinal design of the study. FINDINGS We screened 13,108 women commencing antenatal care at less than 14 weeks and 0 days of gestation, of whom 4607 (35%) were eligible. 4321 (94%) eligible women had pregnancies without major complications and delivered live singletons without congenital malformations (the analysis population). We documented very low maternal and perinatal mortality and morbidity, confirming that the participants were at low risk of adverse outcomes. For each of the five fetal growth measures, the mean differences between the observed and smoothed centiles for the 3rd, 50th, and 97th centiles, respectively, were small: 2·25 mm (SD 3·0), 0·02 mm (3·0), and -2·69 mm (3·2) for head circumference; 0·83 mm (0·9), -0·05 mm (0·8), and -0·84 mm (1·0) for biparietal diameter; 0·63 mm (1·2), 0·04 mm (1·1), and -1·05 mm (1·3) for occipitofrontal diameter; 2·99 mm (3·1), 0·25 mm (3·2), and -4·22 mm (3·7) for abdominal circumference; and 0·62 mm (0·8), 0·03 mm (0·8), and -0·65 mm (0·8) for femur length. We calculated the 3rd, 5th 10th, 50th, 90th, 95th and 97th centile curves according to gestational age for these ultrasound measures, representing the international standards for fetal growth. INTERPRETATION We recommend these international fetal growth standards for the clinical interpretation of routinely taken ultrasound measurements and for comparisons across populations. FUNDING Bill & Melinda Gates Foundation.


Obstetrical & Gynecological Survey | 1982

The timing factor in the pathophysiology of the intrauterine growth retardation syndrome.

J.A. Villar; José M. Belizán

Three different types of intrauterine growth retardation can be identified depending on the moment at which supplies to the fetus are diminished. When a reduction in sustenance occurs early in the first trimester of pregnancy, a well-proportioned but growth-retarded baby may be expected. When the negative factors develop around the 30th week of pregnancy, the result is a disproportionately growth-retarded infant. Both types of retardation can be illustrated using longitudinal uterine height and biparietal diameter values and by neonatal anthropometry. Epidemiological examples exist defining factors which produce these two kinds of retardation. The third type occurs when a reduction in food supplies takes place in the last month of pregnancy and causes a depletion of the fetal fat stored. Weight retardation is observed with little or no height impairment. In planning public health activities such as nutrition interventions for developing countries, the type of intrauterine growth retardation present in the target population should be considered in order to determine which type of intervention would be most appropriate, and establish its correct timing.


Physical Review D | 2002

The IGEX Ge-76 neutrinoless double beta decay experiment: Prospects for next generation experiments

E. García; J. Puimedón; V.S. Pogosov; J. Morales; Walter K. Hensley; A.A. Vasenko; I.G. Irastorza; A.A. Smolnikov; J.H. Reeves; I.V. Kirpichnikov; S. Cebrián; S.B. Osetrov; Harry S. Miley; F. T. Avignone; J.A. Villar; A. Morales; A.S. Starostin; A.G. Tamanyan; R. L. Brodzinski; A.A. Klimenko; S.I. Vasilev; D. González; A. Ortiz de Solórzano; M.L. Sarsa

The International Germanium Experiment (IGEX) has analyzed 117 mole yr of 76Ge data from its isotopically enriched (86% 76Ge) germanium detectors. Applying pulse-shape discrimination (PSD) to the more recent data, the lower bound on the half-life for neutrinoless double-beta decay of 76Ge is:


Journal of Cosmology and Astroparticle Physics | 2007

An improved limit on the axion–photon coupling from the CAST experiment

S. Andriamonje; S. Aune; D. Autiero; K. Barth; A. Belov; B. Beltrán; H. Bräuninger; J. M. Carmona; S. Cebrián; J. I. Collar; T. Dafni; Martyn Davenport; L. Di Lella; C. Eleftheriadis; Jakob Englhauser; G. Fanourakis; E. Ferrer Ribas; H. Fischer; J. Franz; Peter Friedrich; T. Geralis; I. Giomataris; Sergei Gninenko; Haley Louise Gomez; M. Hasinoff; F.H. Heinsius; D. H. H. Hoffmann; I.G. Irastorza; J. Jacoby; K. Jakovčić

T_{1/2}(0\nu)> 1.57 \times 10^{25}


American Journal of Obstetrics and Gynecology | 1978

Diagnosis of intrauterine growth retardation by a simple clinical method: Measurement of uterine height

Jose M. Belizan; J.A. Villar; Juan C. Nardin; Julio Malamud; Lidia Sainz De Vicuña

yr (90% C.L.). This corresponds to an upper bound in the Majorana neutrino mass parameter,


Obstetrics & Gynecology | 2007

Mapping the theories of preeclampsia and the role of angiogenic factors : A systematic review

Mariana Widmer; J.A. Villar; A Benigni; Agustin Conde-Agudelo; S A Karumanchi; Marshall D. Lindheimer


British Journal of Obstetrics and Gynaecology | 2009

World Health Organisation multicentre randomised trial of supplementation with vitamins C and E among pregnant women at high risk for pre‐eclampsia in populations of low nutritional status from developing countries

J.A. Villar; Manorama Purwar; Mario Merialdi; Nelly Zavaleta; N. thi Nhu Ngoc; John Anthony; A. de Greeff; Lucilla Poston; Andrew Shennan

, between 0.33 eV and 1.35 eV, depending on the choice of theoretical nuclear matrix elements used in the analysis.

Collaboration


Dive into the J.A. Villar's collaboration.

Top Co-Authors

Avatar

S. Cebrián

University of Zaragoza

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

J. Morales

University of Zaragoza

View shared research outputs
Top Co-Authors

Avatar

E. García

University of Zaragoza

View shared research outputs
Top Co-Authors

Avatar

M.L. Sarsa

University of Zaragoza

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

A. Morales

University of Zaragoza

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge